beta cells sense glucose through its metabolism and the resulting increase in ATP, which subsequently stimulates insulin secretion. Uncoupling protein-2 (UCP2) mediates mitochondrial proton leak, decreasing ATP production. In the present study, we assessed UCP2's role in regulating insulin secretion. UCP2-deficient mice had higher islet ATP levels and increased glucose-stimulated insulin secretion, establishing that UCP2 negatively regulates insulin secretion. Of pathophysiologic significance, UCP2 was markedly upregulated in islets of ob/ob mice, a model of obesity-induced diabetes. Importantly, ob/ob mice lacking UCP2 had restored first-phase insulin secretion, increased serum insulin levels, and greatly decreased levels of glycemia. These results establish UCP2 as a key component of beta cell glucose sensing, and as a critical link between obesity, beta cell dysfunction, and type 2 diabetes.
Uncoupling protein 3 (UCP3) is a member of the mitochondrial anion carrier superfamily. Based upon its high homology with UCP1 and its restricted tissue distribution to skeletal muscle and brown adipose tissue, UCP3 has been suggested to play important roles in regulating energy expenditure, body weight, and thermoregulation. Other postulated roles for UCP3 include regulation of fatty acid metabolism, adaptive responses to acute exercise and starvation, and prevention of reactive oxygen species (ROS) formation. To address these questions, we have generated mice lacking UCP3 (UCP3 knockout (KO) mice). Here, we provide evidence that skeletal muscle mitochondria lacking UCP3 are more coupled (i.e. increased state 3/state 4 ratio), indicating that UCP3 has uncoupling activity. In addition, production of ROS is increased in mitochondria lacking UCP3. This study demonstrates that UCP3 has uncoupling activity and that its absence may lead to increased production of ROS. Despite these effects on mitochondrial function, UCP3 does not seem to be required for body weight regulation, exercise tolerance, fatty acid oxidation, or cold-induced thermogenesis. The absence of such phenotypes in UCP3 KO mice could not be attributed to up-regulation of other UCP mRNAs. However, alternative compensatory mechanisms cannot be excluded. The consequence of increased mitochondrial coupling in UCP3 KO mice on metabolism and the possible role of yet unidentified compensatory mechanisms, remains to be determined. Uncoupling protein 3 (UCP3)1 (1-3) is a member of the mitochondrial anion carrier superfamily with high homology (57%) to UCP1, a well characterized uncoupling protein (4, 5). UCP3 together with UCP1, UCP2 (6, 7), and possibly BMCP1 (brain mitochondrial carrier protein) (8) and UCP4 (9), form a family of uncoupling proteins located in the inner mitochondrial membrane. The evidence supporting the uncoupling activity of these proteins comes from studies where UCPs have been heterologously expressed in yeast or reconstituted into proteoliposomes. The expression of UCP2 and -3 decreases the mitochondrial membrane potential, as assessed by uptake of fluorescent membrane potential-sensitive dyes in whole yeast. They also increase state 4 respiration in isolated mitochondria, which serves as an indicator of inner membrane proton leak (3, 6, 10). More recently, reconstitution of UCPs into liposomes has shown that UCP2 and UCP3, like UCP1, mediate proton transport across bilipid layers (11). It is well established that UCP1 is exclusively expressed in brown fat, where it plays a key role in facultative thermogenesis in rodents. Although there is controversy about the molecular mechanisms involved (12-16), it is clear that activated UCP1 catalyzes a proton leak across the mitochondrial inner membrane leading to thermogenesis. The activity of UCP1 is highly regulated, facilitated by fatty acids and inhibited by purine ribose di-and trinucleotides (ATP, ADP, GTP, GDP) (17). UCP1 is also highly regulated at the transcriptional level (18) by cat...
3-Adrenergic receptors (3-ARs) are expressed predominantly on white and brown adipocytes, and acute treatment of mice with CL 316,243, a potent and highly selective 3-AR agonist, produces a 2-fold increase in energy expenditure, a 50 -100-fold increase in insulin levels, and a 40 -50% reduction in food intake. Recently, we generated gene knockout mice lacking functional 3-ARs and demonstrated that each of these responses were mediated exclusively by 3-ARs. However, the tissue site responsible for producing these actions is unknown. In the present study, genetically engineered mice were created in which 3-ARs are expressed exclusively in white and brown adipocytes (WAT؉BAT-mice), or in brown adipocytes only (BAT-mice). This was accomplished by injecting tissue-specific 3-AR transgenic constructs into mouse zygotes homozygous for the 3-AR knockout allele. Control, knockout, WAT؉BAT, and BAT-mice were then treated acutely with CL, and the effects on various parameters were assessed. As previously observed, all effects of CL were completely absent in gene knockout mice lacking 3-ARs. The effects on O 2 consumption, insulin secretion, and food intake were completely rescued with transgenic re-expression of 3-ARs in white and brown adipocytes (WAT؉BAT-mice), demonstrating that each of these responses is mediated exclusively by 3-ARs in white and/or brown adipocytes, and that 3-ARs in other tissue sites were not required. Importantly, transgenic re-expression of 3-ARs in brown adipocytes only (BAT-mice) failed to rescue, in any way, CL-mediated effects on insulin levels and food intake and only minimally restored effects on oxygen consumption, indicating that any effect on insulin secretion and food intake, and a full stimulation of oxygen consumption required the presence of 3-ARs in white adipocytes. The mechanisms by which 3-AR agonist stimulation of white adipocytes produces these responses are unknown but may involve novel mediators not previously known to effect these processes.Obesity is a prevalent condition frequently associated with diabetes, hypertension, and cardiovascular disease. Because available treatments are minimally effective, substantial efforts have been directed toward the discovery of new, effective, anti-obesity drugs. The 3-adrenergic receptor (3-AR) 1 represents one of a number of potential anti-obesity drug targets for which selective agonists have been developed (1-3). The 3-AR is encoded by a distinct gene that is expressed predominantly in white and brown adipocytes (4 -7), important sites for energy storage and energy expenditure, respectively. Selective activation of 3-ARs leads to marked increases in triglyceride breakdown (lipolysis) and energy expenditure (1-3), and long term treatment of obese rodents with 3-selective agonists reduces fat stores and improves obesity-induced insulin resistance (1-3). Thus, 3-selective agonists are promising anti-obesity compounds.Acute treatment of rodents with 3-selective agonists causes a number of diverse metabolic effects in...
The factors that regulate gene expression of uncoupling proteins 2 and 3 (UCP-2 and UCP-3) in skeletal muscle are poorly understood, but both genes are clearly responsive to the metabolic state of the organism. Therefore, we tested the hypothesis that denervation and acute and/or chronic exercise (factors that profoundly affect metabolism) would alter UCP-2 and UCP-3 gene expression. For the denervation studies, the sciatic nerve of rat and mouse hindlimb was sectioned in one leg while the contralateral limb served as control. Northern blot analysis revealed that denervation was associated with a 331% increase ( P < 0.001) in UCP-3 mRNA and a 200% increase ( P < 0.01) in UCP-2 mRNA levels in rat mixed gastrocnemius (MG) muscle. In contrast, denervation caused a 53% decrease ( P< 0.001) in UCP-3 and a 63% increase ( P < 0.01) in UCP-2 mRNA levels in mouse MG. After acute exercise (2-h treadmill running), rat UCP-3 mRNA levels were elevated (vs. sedentary control) 252% ( P < 0.0001) in white gastrocnemius and 63% ( P < 0.05) in red gastrocnemius muscles, whereas UCP-2 levels were unaffected. To a lesser extent, elevations in UCP-3 mRNA (22%; P < 0.01) and UCP-2 mRNA (55%; P < 0.01) levels were observed after acute exercise in the mouse MG. There were no changes in either UCP-2 or UCP-3 mRNA levels after chronic exercise (9 wk of wheel running). These results indicate that acute exercise and denervation regulate gene expression of skeletal muscle UCPs.
Catecholamines play an important role in controlling white adipose tissue function and development. -and ␣2-adrenergic receptors (ARs) couple positively and negatively, respectively, to adenylyl cyclase and are coexpressed in human adipocytes. Previous studies have demonstrated increased adipocyte ␣2/-AR balance in obesity, and it has been proposed that increased ␣2-ARs in adipose tissue with or without decreased -ARs may contribute mechanistically to the development of increased fat mass. To critically test this hypothesis, adipocyte ␣2/-AR balance was genetically manipulated in mice. Human ␣2A-ARs were transgenically expressed in the adipose tissue of mice that were either homozygous (؊/؊) or heterozygous (؉/؊) for a disrupted 3-AR allele. Mice expressing ␣2-ARs in fat, in the absence of 3-ARs (3-AR ؊/؊ background), developed high fat diet-induced obesity. Strikingly, this effect was due entirely to adipocyte hyperplasia and required the presence of ␣2-ARs, the absence of 3-ARs, and a high fat diet. Of note, obese ␣2-transgenic, 3 ؊/؊ mice failed to develop insulin resistance, which may reflect the fact that expanded fat mass was due to adipocyte hyperplasia and not adipocyte hypertrophy. In summary, we have demonstrated that increased ␣2/-AR balance in adipocytes promotes obesity by stimulating adipocyte hyperplasia. This study also demonstrates one way in which two genes (␣2 and 3-AR) and diet interact to influence fat mass.
Nonshivering thermogenesis in brown adipose tissue (BAT) provides heat through activation of a mitochondrial uncoupling protein (UCP1), which causes futile electron transport cycles without the production of ATP. Recent discovery of two molecular homologues, UCP2, expressed in multiple tissues, and UCP3, expressed in muscle, has resulted in investigation of their roles in thermoregulatory physiology and energy balance. To determine the expression pattern of Ucp homologues in hibernating mammals, we compared relative mRNA levels of Ucp1, -2, and -3 in BAT, white adipose tissue (WAT), and skeletal muscle of arctic ground squirrels ( Spermophilus parryii) hibernating at different ambient and body temperatures, with levels determined in tissues from ground squirrels not in hibernation. Here we report significant increases in mRNA levels for Ucp2 in WAT (1.6-fold) and Ucp3 in skeletal muscle (3-fold) during hibernation. These results indicate the potential for a role of UCP2 and UCP3 in thermal homeostasis during hibernation and indicate that parallel mechanisms and multiple tissues could be important for nonshivering thermoregulation in mammals.
Uncoupling protein-3 (UCP3) is a recently identified candidate mediator of adaptive thermogenesis in humans. Unlike UCP1 and UCP2, UCP3 is expressed preferentially and at high levels in human skeletal muscle and exists as short and long form transcripts, UCP3 S and UCP3 L . UCP3 S is predicted to encode a protein which lacks the last 37 C-terminal residues of UCP3 L . In the present study, we have defined the intron-exon structure for the human UCP3 gene and determined that UCP3 S is generated when a cleavage and polyadenylation signal (AATAAA) located in the last intron prematurely terminates message elongation. In addition we have mapped UCP3 to the distal segment of human chromosome 11q13 (between framework markers D11S916 and D11S911), adjacent to UCP2. Of note, UCP2 and UCP3 in both mice and humans colocalize in P1 and BAC genomic clones indicating that these two UCPs are located within 75-150 kilobases of each other and most likely resulted from a gene duplication event. Previous studies have noted that mouse UCP2 maps to a region of chromosome 7 which is coincident with three independently mapped quantitative trait loci for obesity. Our study shows that UCP3 is also coincident with these quantitative trait loci raising the possibility that abnormalities in UCP3 are responsible for obesity in these models.The control of body weight involves a regulated balance between energy intake and expenditure. Energy expenditure can be divided into three components (1): resting metabolic rate, physical activity, and adaptive thermogenesis, the latter being defined as the component of energy expenditure that changes in response to environmental stimuli such as cold exposure or chronic dietary excess. In rodents, an important site of adaptive thermogenesis is brown adipose tissue (reviewed in Ref.2) where uncoupling protein-1 (UCP1), 1 expressed exclusively in brown adipocytes (3, 4), promotes proton transport across the mitochondrial inner membrane. UCP1 decreases the proton electrochemical potential gradient, uncoupling fuel oxidation from ADP availability (reviewed in Refs. 5 and 6). Activation of UCP1, therefore, causes increased consumption of calories and generation of heat. UCP1-mediated effects on energy expenditure are regulated by changes in the level of sympathetic nervous system activity in brown fat. Cold exposure and overfeeding cause increased sympathetic stimulation of brown fat, simulating UCP1-mediated uncoupling and energy expenditure. The importance of this is demonstrated by the fact that mice lacking UCP1 are cold-intolerant (7). UCP1 is also regulated by purine di-and trinucleotides (ATP, ADP, GTP, and GDP) and free fatty acids, which inhibit and stimulate uncoupling activity, respectively (reviewed in Refs. 5 and 6).UCP1 may be of lesser importance in humans in whom the mass of brown adipose tissue is limited. Instead, skeletal muscle is thought to be a major site of adpative thermogenesis (8 -12). UCP2 (13-15) is a recently described UCP1 homologue which, unlike UCP1, is expressed in most tissue...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.